Product correctly added to cart.

discount label
Rilapladib
View 3D

Targetmol logo

Rilapladib

CAS: 412950-08-4

Ref. TM-T16751

1mg
91.00 €
5mg
222.00 €
10mg
364.00 €
25mg
609.00 €
50mg
866.00 €
100mg
1,179.00 €
1mL*10mM (DMSO)
367.00 €
Estimated delivery in United States, on Monday 10 Mar 2025

Product Information

Name:
Rilapladib
Synonyms:
  • SB 659032
  • 1(4H)-Quinolineacetamide, 2-[[(2,3-difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4′-(trifluoromethyl)[1,1′-biphenyl]-4-yl]methyl]-
  • 2-[[(2,3-Difluorophenyl)methyl]thio]-N-[1-(2-methoxyethyl)-4-piperidinyl]-4-oxo-N-[[4'-(trifluoromethyl)[1,1'-biphenyl]-4-yl]methyl]-1(4H)-quinolineacetamide
  • N-[1-(2-Methoxyethyl)piperidin-4-yl]-2-[2-[(2,3-difluorobenzyl)thio]-4-oxo-4H-quinolin-1-yl]-N-[(4′-trifluoromethylbiphenyl-4-yl)methyl]acetamide
  • Sb 659032
Description:

Rilapladib (SB 659032) is a selective inhibitor of Lipoprotein-Associated Phospholipase A2(Lp-PLA2, IC50 = 230 pM) and an antagonist of the platelet activating

Notice:
Our products are intended for lab use only. For any other use, please contact us.
Brand:
Targetmol
Long term storage:
Notes:

Chemical properties

Molecular weight:
735.8
Formula:
C40H38F5N3O3S
Purity:
97.29%
Color/Form:
Solid
MDL:
Melting point:
Boiling point:
Flash point:
Density:
Concentration:
EINECS:
Merck:
HS code:

Hazard Info

UN Number:
EQ:
Class:
H Statements:
P Statements:
Forbidden to fly:
Hazard Info:
Packing Group:
LQ:

Technical inquiry about: TM-T16751 Rilapladib

Please use instead the cart to request a quotation or an order

If you want to request a quotation or place an order, please instead add the desired products to your cart and then request a quotation or order from the cart. It is faster, cheaper, and you will be able to benefit from the available discounts and other advantages.

* Mandatory fields.
Welcome to CymitQuimica!We use cookies to enhance your visit. We do not include advertising.

Please see our Cookies Policy for more details or adjust your preferences in "Settings".